Percutaneous radiofrequency ablation of hepatocellular carcinoma on cirrhosis: State of the art and future perspectives

Recent Patents on Anti-Cancer Drug Discovery

Volumn 5, Issue 1, 2010, Pages 69-76

  Giorgio, Antonio ^a  

^a AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

Author keywords

Cirrhosis; Hepatocellular carcinoma; Percutaneous interventional ultrasound; Radiofrequency ablation

Indexed keywords

ALCOHOL;

ARTICLE; CANCER CONTROL; CANCER GROWTH; CANCER SURVIVAL; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NONHUMAN; PERCUTANEOUS RADIOFREQUENCY ABLATION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR NECROSIS; CATHETER ABLATION; CLINICAL TRIAL; ECHOGRAPHY; INSTRUMENTATION; INTRADERMAL DRUG ADMINISTRATION; LIVER TUMOR; METHODOLOGY; NECROSIS; PATHOLOGY; REVIEW; SURVIVAL; THROMBECTOMY;

ADMINISTRATION, CUTANEOUS; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CLINICAL TRIALS AS TOPIC; ETHANOL; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; NECROSIS; SURVIVAL ANALYSIS; THROMBECTOMY;

EID: 77649266459     PISSN: 15748928     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489210789702226     Document Type: Article

References (73)

1. Monto A, Wright TL. The epidemiology and prevention ofhepatocellular carcinoma. Semin Oncol 2001; 28 (5): 441-449.
2. Fattovich G, Stroffolini T, Zagni I, Donato E. Hepatocellularcarcinoma in cirrhosis: Incidence and risk factors. Gastroenterol 2004; 127 (5 Suppl): S53-50.
3. Masami M, Makuuchi M. Treatment of hepatocellular carcinomaaccompanied by portal vein tumor thrombus. World J Gastroenterol 2006; 21 (47): 7561-7567.
4. Takizawa D, Kakizaki S, Sohara N, et al. Hepatocellular carcinomawith portal vein tumor thrombosis: Clinical characteristics,prognosis, and patient survival analysis. Dig Dis Sci 2007; 52 (11):3290-3295.
5. Reichman TW, Tiffany A, Millis JM, Testa G. Uncharacteristicallyearly fatal intraperitoneal rupture of hepatocellular carcinomafollowing transarterial chemoembolisation. Dig Liver Dis 2009; 41:175-176.
6. Bruix J, Sherman M, Llovet JM, et al. Clinical management ofhepatocellular carcinoma. Conclusion of the Barcelona-2000 EASL-Conference. J Hepatol 2001; 35: 421-430.
7. Richard, H. M., Gullapalli, R. P., Zhang, B.: US20080146912 (2008).
8. Solbiati L, Ierace T, Tonolini M, Cova L. Guidance and monitoringof radiofrequency liver tumor ablation with contrast-enhancedultrasound. Eur J Radiol 2004; 51 (Suppl): S19-23.
9. Giorgio A, de Stefano G, Farella N, et al. Percutaneous echo-guidedablation of hepatocellular carcinoma (HCC), guidance andmonitoring with contrast enhanced ultrasound (CEUS). Dig LiverDis 2009; 41 (A11): 5.
10. Rossi S, Di Stasi M, Buscarini E, et al. Percutaneous RF interstitialthermal ablation in the treatment of hepatic cancer. Am JRoentgenol 1996; 167: 759-768.
11. Buscarini L, Fornari F, Rossi S. Interstitial radiofrequencyhyperthermia in the treatment of small hepatocellular carcinoma:Percutaneous US-guided of electrode needle. In: Anderegg A,Desplaned PA, Otto R, Henner H, Eds. Ultraschall-diagnostik 91;Berlin: Springer-Verlag 1992: 218-222.
12. Rossi S, Fornari F, Buscarini L. Percutaneous ultrasound-guidedradiofrequency electrocautery for the treatment of smallhepatocellular carcinoma. J Intervent Radiol 1993; 8: 97-103.
13. Rossi S, Di Stasi M, Buscarini E, et al. Percutaneousradiofrequency interstitial thermal ablation in the treatment of smallhepatocellular carcinoma. Cancer J Sci Am 1995; 1: 73-81.
14. Seror O, N'Kontchon G, Ibralium M, et al. Large (> or = 5cm)HCCs: Multipolar RF ablation with three internally coded bipolarelectrodes: Initial experience in 26 patients. Radiology 2008; 248(1): 288-96.
15. Giorgio A, de Stefano G, Ferraioli G. Multipolar RF ablation oflarge HCC on cirrhosis. Proceeding Euroson 2006.
16. Shibata T, Shibata T, Maetani Y, Isoda H, Hiraoka M. Radiofrequency ablation for small hepatocellular carcinoma:Prospective comparison of internally cooled electrode andexpandable electrode. Radiology 2006; 238 (1): 346-353.
17. Giorgio A, Tarantino L, de Stefano G, et al. Percutaneoussonographically guided saline-enhanced radiofrequency ablation ofhepatocellular carcinoma. Am J Roentgenol 2003; 181 (2): 479-484.
18. Lin SM, Lin CC, Chen WT, Chen YC, Hsu CW. Radiofrequencyablation for hepatocellular carcinoma: A prospective comparison offour radiofrequency devices. J Vasc Interv Radiol 2007; 18 (9):1118-1125.
19. Hänsier J, Frieser M, Tietz V, et al. Percutaneous radiofrequencyablation of liver tumors using multiple saline-perfused electrodes. J Vasc Interv Radiol 2007; 18 (3): 405-410.
20. Livraghi T, Lazzaroni S, Meloni F. Radiofrequency thermalablation of hepatocellular carcinoma. Eur J Ultrasound 2001; 13:159-166.
21. Goldberg SN, Kamel IR, Kruskal JB, et al. Radiofrequency ablationof hepatic tumors: Increased tumor destruction with adjuvantliposomal doxorubicin therapy. Am J Roentgenol 2002; 179: 93-101.
22. Rossi S, Garbagnati F, Lencioni R, et al. Percutaneousradiofrequency ablation of nonresectable HCC after occlusion oftumor blood supply. Radiology 2000; 217: 119-126.
23. Pacella CM, Bizzarri G, Cecconi P, et al. HCC: Long-term resultsof combined treatment with laser thermal ablation and TACE. Radiology 2001; 219: 669-678.
24. Kurkochi K, Watanabe S, Masaki T, et al. Comparison betweencombination therapy of PEI and RFA alone for patients with HCC. World J Gastroenterol 2005; 11: 1426-1432.
25. Seror O, N'Kontchon G, Haddar D, et al. Large infiltrative HCC:Treatment with percutaneous intraarterial ethanol injection alone orin combination with conventional PEI. Radiology 2005; 234: 299-309.
26. Seror O, N'Kontchou G, Tin Htar TM, et al. Ethanol versusradiofrequency ablation for treatment of small hepatocellularcarcinoma in patients with cirrhosis: A retrospective study ofefficacy and cost. Gastroenterol Clin Biol 2006; 30 (11): 1265-1273.
27. Curley SA, Izzo F, Ellis LM, Nicolas VJ, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patientswith cirrhosis. Ann Surg 2000; 232: 381-391.
28. Rossi S, Buscarini E, Fornari F, et al. Percutaneous treatment ofsmall hepatic tumors by an expandable RF needle electrode. Am J Roentgenol 1998; 170 (4):1015-1022.
29. Lencioni R, Crocetti L, Pina MC, Cioni D. Percutaneous image-guided radiofrequency ablation of liver tumors. Abdom Imaging 2009; 34(5): 547-56.
30. Livraghi T, Goldberg SN, Lazzaroni S, et al. Hepatocellularcarcinoma: Radio-frequency ablation of medium and large lesions. Radiology 2000; 214 (3): 761-768.
31. Mazzaferro V, Battiston C, Perrone S, et al. Radiofrequencyablation of small hepatocellular carcinoma in cirrhotic patientsawaiting liver transplantation: A prospective study. Ann Surg 2004:240: 900-909.
32. Lu DS, Yu NC, Raman SS, et al. Radiofrequency ablation ofhepatocellular carcinoma: Success as defined by histologicexamination of the explanted liver. Radiology 2005; 234 (3): 954-960.
33. Lu DS, Yu NC, Tso WK, et al. Percutaneous radiofrequencyablation of hepatocellular carcinoma as a bridge to livertransplantation. Hepatology 2005; 41: 1130-1137.
34. Yamasaki T, Kimura T, Kurokawa F, et al. Percutaneousradiofrequency ablation with cooled electrodes combined withhepatic arterial balloon occlusion in hepatocellular carcinoma. J Gastroenterol 2005; 40 (2):171-178.
35. Sakr AA, Saleh AA, Moeaty AA, Moeaty AA. The combined effectof radiofrequency and ethanol ablation in the management of largehepatocellular carcinoma. Eur J Radiol 2005; 54 (3): 418-425.
36. Lencioni R, Crocetti L, Petruzzi P, et al. Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: Apilot clinical study. J Hepatol 2008; 49 (2): 217-222.
37. Ozeki, T.: US20060293386A1 (2006).
38. Noujaim, A., Person, R. H., Stewart, M. W., Hirsche, B. D.:US20070098724 (2007).
39. Buscarini L, Buscarini E, Di Stasi M, et al. Percutaneousradiofrequency ablation of small hepatocellular carcinoma: Long-term results. Eur Radiol 2001; 11 (6): 914-921.
40. Lencioni R, Cioni D, Crocetti L, et al. Early-stage hepatocellularcarcinoma in patients with cirrhosis: Long-term results ofpercutaneous image-guided radiofrequency ablation. Radiology 2005; 234: 961-967.
41. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Radiofrequencyablation improves prognosis compared with ethanol injection forhepatocellular carcinoma < 4cm. Gastroenterology 2004; 127:1714-1723.
42. Shiina S, Teratani T, Obi S, et al. A randomised controlled trial ofradiofrequency ablation with ethanol injection for smallhepatocellular carcinoma. Gastroenterology 2005; 129: 122-130.
43. Brunello F, Veltri A, Carucci P, et al. Radiofrequency ablationversus ethanol injection for early hepatocellular carcinoma: Arandomised controlled trial. Scand J Gastroenterol 2008; 43 (6):727-735.
44. Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanable KK. Treatment of intrahepatic malignancy with radiofrequency ablation:Radiologic-pathologic correlation. Cancer 2000; 88 (11): 2452-2463.
45. Livraghi T, Solbiati L, Meloni MF, et al. Treatment of focal livertumors with percutaneous radio-frequency ablation: Complicationsencountered in a multicenter study. Radiology 2003; 226: 441-451.
46. Zagoria RJ, Chen MY, Shen P, Levine EA. Complications fromradiofrequency ablation of liver metastases. Am Surg 2002; 68:204-209.
47. Buscarini E, Buscarini L. Radiofrequency thermal ablation withexpandable needle of focal liver malignancies: Complication report. Eur Radiol 2004; 14: 31-37.
48. de Baère T, Risse O, Kuoch V, et al. Adverse events duringradiofrequency treatment of 582 hepatic tumors. Am J Roentgenol 2003; 181: 695-700.
49. Giorgio A, Tarantino L, de Stefano G, Coppola C, Ferraioli G. Complications after percutaneous saline-enhanced radiofrequencyablation of liver tumors: 3-year experience with 336 patients at asingle center. Am J Roentgenol 2005; 184: 207-211.
50. Kang TW, Rhim H, Kim EY, et al. Percutaneous radiofrequencyablation for the hepatocellular carcinoma abutting the diaphragm:Assessment of safety and therapeutic efficacy. Korean J Radiol 2009; 10 (1): 34-42.
51. Lee MW, Kim YJ, Park SW, et al. Percutaneous radiofrequencyablation of liver dome hepatocellular carcinoma invisible onultrasonography: A new targeting strategy. Br J Radiol 2008; 81(965): e130-134.
52. Seror O, Haddar D, N'Kontchou G, et al. radiofrequency ablationfor the treatment of liver tumors in the caudate lobe. J Vasc IntervRadiol 2005; 16 (7): 981-190.
53. Giorgio A, Ferraioli G. Liver abscess formation afterradiofrequency ablation in patients with hepatocellular carcinoma. Am J Roentgenol 2006; 186 (2): 582-583.
54. Francica G, Iodice G, Marone G. Acute thermal injury of thegallbladder in the course of interstitial radiofrequency hyperthermiatreatment for hepatocellular carcinoma. Eur J Ultrasound 1996; 4:123-127.
55. Chopra S, Dodd GD 3rd, Chanin MP, Chintapalli KN. Radio-frequency ablation of hepatic tumors adjacent to the gallbladder:Feasibility and safety. Am J Roentgenol 2003; 180 (3): 697-701.
56. Livraghi T, Goldberg SN, Lazzaroni S, et al. Small hepatocellularcarcinoma: Treatment with radio-frequency ablation versus ethanolinjection. Radiology 1999; 210: 655-661.
57. Lencioni RA, Allgaier HP, Cioni D, et al. Small hepatocellularcarcinoma in cirrhosis: Randomized comparison of radio-frequencythermal ablation versus percutaneous ethanol injection. Radiology 2003; 228 (1): 235-240.
58. Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trialcomparing percutaneous local ablative therapy and partialhepatectomy for small hepatocellular carcinoma. Ann Surg 2006;243 (3): 321-328.
59. Livraghi T, Meloni F, Di Stasi M, et al. Sustained completeresponse and complications rates after radiofrequency ablation ofvery early hepatocellular carcinoma in cirrhosis: Is resection stillthe treatment of choice? Hepatology 2008; 47 (1): 82-89.
60. Orlando A, Leandro G, Olivo M, Andriulli A, Cottone M.Radiofrequency thermal ablation vs. percutaneous ethanol injectionfor small hepatocellular carcinoma in cirrhosis: Metaanalysis ofrandomized controller trials. Am J Gastroenterol 2009; 104 (2):514-524.
61. Cho YK, Kim JK, Kim MY, Rhim H, Han JK. Systematic review ofrandomized trials for hepatocellular carcinoma treated withpercutaneous ablation therapies. Hepatology 2009; 49 (2): 453-459.
62. Bouza C, Cuadrado TL, Alcàzar R, Parkinson ZS, Amate JM. Meta-analysis of percutaneous radiofrequency ablation versusethanol injection in hepatocellular carcinoma. BMC Gastroenterol 2009; 9: 31-39.
63. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42:1208-1236.
64. Abdel-Wahab M, El-Ghawalby N, Mostafa M, et al. Epidemiologyof hepatocellular carcinoma in lower Egypt, MansouraGastroenterology Center. Hepatogastroenterology 2007; 54 (73):157-162.
65. Elefsiniotos IS, Diamantis ID, Dourakis SP, et al. Anticardiolipinantibodies in chronic hepatitis B and chronic hepatitis D infection,and hepatitis B-related hepatocellular carcinoma. Relationship withportal vein thrombosis. Eur Gastroenterol Hepatol 2003; 15 (7):721-726.
66. Fujii T, Takayasu K, Muramatsu Y, et al. Hepatocellular carcinomawith portal tumor thrombus: Analysis of factors determiningprognosis. Jpn J Clin Oncol 1993; 23 (2): 105-109.
67. Rabe C, Pilz T, Klostermann C, et al. Clinical characteristics andoutcome of a cohort of 101 patients with hepatocellular carcinoma. World J Gastroenterol 2001; 7 (2): 208-215.
68. Llovet JM, Bustamante J, Castells A, et al. Natural history ofuntreated non surgical hepatocellular carcinoma: Rationale for thedesign and evaluation of therapeutic trials. Hepatology 1999; 29:62-67.
69. Villa E, Moles A, Ferretti I, et al. Natural history of inoperablehepatocellular carcinoma: Estrogen receptors' status in the tumor isthe strongest prognostic factor for survival. Hepatology 2000; 32:535-539.
70. Giorgio A, Tarantino L, de Stefano G, et al. Ultrasound-guidedpercutaneous ethanol injection under general anaesthesia for thetreatment of hepatocellular carcinoma on cirrhosis: Long-termresults in 268 patients. Eur J Ultrasound 2000; 12 (2): 145-54.
71. Giorgio A, de Stefano G, Di Sarno A, et al. Radiofrequencyablation of hepatocellular carcinoma extended into the portal vein:Preliminary results. J Ultrasound 2009; 12: 32-37.
72. Giorgio A, de Stefano G, Di Sarno A, et al. Radiofrequencyablation of both medium size hepatocellular carcinoma (HCC) andaccompanied with main portal venous (MPV) tumor thrombus incirrhotic patients: A case control study. Dig Liver Dis 2009; 41: A7.
73. Giorgio A, Di Sarno A, de Stefano G, et al. Hepatocellularcarcinoma with cirrhosis: Are patients with neoplastic main portalvein invasion eligible for percutaneous radiofrequency ablation ofboth the nodule and the portal venous tumor thrombus? Am J Roentgenol 2009; 193: (in press).